These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8480594)

  • 1. Definition and measurement of restenosis after successful coronary angioplasty: implications for clinical trials.
    Lespérance J; Bourassa MG; Schwartz L; Hudon G; Laurier J; Eastwood C; Kazim F
    Am Heart J; 1993 May; 125(5 Pt 1):1394-408. PubMed ID: 8480594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: quantitative angiographic analysis in 778 lesions--further evidence for the restenosis paradox. MERCATOR Study Group (Multicenter European Research trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
    Hermans WR; Foley DP; Rensing BJ; Serruys PW
    Am Heart J; 1994 Mar; 127(3):483-94. PubMed ID: 8122593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term luminal renarrowing after successful elective coronary angioplasty of total occlusions. A quantitative angiographic analysis.
    Violaris AG; Melkert R; Serruys PW
    Circulation; 1995 Apr; 91(8):2140-50. PubMed ID: 7697842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty.
    Foley DP; Melkert R; Serruys PW
    Circulation; 1994 Sep; 90(3):1239-51. PubMed ID: 8087933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matching based on quantitative coronary angiography as a surrogate for randomized studies: comparison between stent implantation and balloon angioplasty of native coronary artery lesions.
    de Jaegere PP; Hermans WR; Rensing BJ; Strauss BH; de Feyter PJ; Serruys PW
    Am Heart J; 1993 Feb; 125(2 Pt 1):310-9. PubMed ID: 8427121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of serum cholesterol and cholesterol subfractions on restenosis after successful coronary angioplasty. A quantitative angiographic analysis of 3336 lesions.
    Violaris AG; Melkert R; Serruys PW
    Circulation; 1994 Nov; 90(5):2267-79. PubMed ID: 7955183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.
    Foley DP; Melkert R; Umans VA; de Jaegere PP; Strikwerda S; de Feyter PJ; Serruys PW
    Eur Heart J; 1995 Oct; 16(10):1331-46. PubMed ID: 8746901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing comprehensive, quantitative criteria for detection of restenosis and remodeling after percutaneous transluminal coronary angioplasty.
    de Cesare NB; Williamson PR; Moore NB; DeBoe SF; Mancini GB
    Am J Cardiol; 1992 Jan; 69(1):77-83. PubMed ID: 1729871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of quantitative digital subtraction coronary angiography before and after percutaneous transluminal coronary angioplasty.
    Sanz ML; Mancini J; LeFree MT; Mickelson JK; Starling MR; Vogel RA; Topol EJ
    Am J Cardiol; 1987 Jul; 60(1):55-60. PubMed ID: 2955693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologic response to gain and loss in coronary minimal luminal diameter in patients treated with coronary angioplasty: prediction of restenosis on the basis of exercise capacity.
    Jørgensen B; Simonsen S; Endresen K; Forfang K; Egeland T; Thaulow E
    Am Heart J; 2000 Mar; 139(3):482-90. PubMed ID: 10689263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months.
    Serruys PW; Luijten HE; Beatt KJ; Geuskens R; de Feyter PJ; van den Brand M; Reiber JH; ten Katen HJ; van Es GA; Hugenholtz PG
    Circulation; 1988 Feb; 77(2):361-71. PubMed ID: 2962786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in reference vessel diameter following intracoronary stent implantation: important consequences for restenosis based on percent diameter stenosis.
    Foley JB
    Cathet Cardiovasc Diagn; 1995 Jun; 35(2):103-9. PubMed ID: 7656300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restenosis revisited: insights provided by quantitative coronary angiography.
    Serruys PW; Foley DP; Kirkeeide RL; King SB
    Am Heart J; 1993 Nov; 126(5):1243-67. PubMed ID: 8237780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty. The ACCORD Study. Angioplastic Coronaire Corvasal Diltiazem.
    Lablanche JM; Grollier G; Lusson JR; Bassand JP; Drobinski G; Bertrand B; Battaglia S; Desveaux B; Juillière Y; Juliard JM; Metzger JP; Coste P; Quiret JC; Dubois-Randé JL; Crochet PD; Letac B; Boschat J; Virot P; Finet G; Le Breton H; Livarek B; Leclercq F; Béard T; Giraud T; Bertrand ME
    Circulation; 1997 Jan; 95(1):83-9. PubMed ID: 8994421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability of quantitative coronary angiography of the target lesion immediately and 1 day after coronary balloon and excimer laser angioplasty.
    Preisack MB; Athanasiadis A; Voelker W; Karsch KR
    J Am Coll Cardiol; 1993 Mar; 21(4):876-84. PubMed ID: 8450156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early decrease in minimal luminal diameter after successful percutaneous transluminal coronary angioplasty predicts late restenosis.
    Rodriguez A; Santaera O; Larribeau M; Sosa MI; Palacios IF
    Am J Cardiol; 1993 Jun; 71(16):1391-5. PubMed ID: 8517382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group.
    Foley DP; Bonnier H; Jackson G; Macaya C; Shepherd J; Vrolix M; Serruys PW
    Am J Cardiol; 1994 May; 73(14):50D-61D. PubMed ID: 8198025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of elastic recoil on restenosis after successful coronary angioplasty in unstable angina pectoris.
    Ardissino D; Di Somma S; Kubica J; Barberis P; Merlini PA; Eleuteri E; De Servi S; Bramucci E; Specchia G; Montemartini C
    Am J Cardiol; 1993 Mar; 71(8):659-63. PubMed ID: 8447261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and one year follow-up results after vessel size adapted PTCA using intracoronary ultrasound.
    Haase KK; Athanasiadis A; Mahrholdt H; Treusch A; Wullen B; Jaramillo C; Baumbach A; Voelker W; Meisner C; Karsch KR
    Eur Heart J; 1998 Feb; 19(2):263-72. PubMed ID: 9519320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.